ArticleInternational journal of environmental research and public health2022
Family Life Cycle, Asset Portfolio, and Commercial Health Insurance Demand in China.
Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A study on the current status of collaboration between China's commercial health insurance and medical institutions and improvement strategies.BMC health services research · 2026Article
- Prevalence and Intensity of Catastrophic Health Expenditure Among Residents in a Multiethnic Province in China: Cross-Sectional Study.JMIR public health and surveillance · 2025Article
- Effect of households' members disability and serious illness on public health insurance subscription among urban refugees during the COVID-19 pandemic in Kenya.BMC public health · 2024Article
- Article
- Article
- Study on the Dynamic Relationship between Chinese Residents' Individual Characteristics and Commercial Health Insurance Demand.International journal of environmental research and public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on the cross-sectional data of the China household finance survey (CHFS) in 2017, this paper aims to empirically examine the effects of the family life cycle, financial status, and asset portfolio on commercial health insurance demand (breadth and depth) by constructing Probit and Tobit models, respectively. Based on all of the samples, it has been found that family life cycle, family financial status, and family asset portfolio have different influences on the breadth and the depth of health insurance. In terms of the family life cycle, there is an "inverted U-shaped" relationship with the breadth and the depth of health insurance, and the effect is obvious. In terms of family financial status, total household consumption has positive and significant effects on the breadth and depth of health insurance. Total household income and total household debt only have a significant positive impact on health insurance breadth. The total household asset portfolio is only positively correlated with health insurance depth. In terms of the family asset portfolio, the share of real estate assets has a crowding out effect on the breadth and the depth of health insurance. The share of savings assets has no significant effect on the breadth and the depth of health insurance but is positively correlated with the former and negatively correlated with the latter. Both the share of vehicle assets and the share of investment assets only have a significant impact on the breadth of health insurance; however, the positive and negative correlation is different. Based on the sub-samples, it has been found that the breadth and the depth of health insurance vary greatly in the regions and household registration characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.